Medicare Advantage Enrollees Face Higher Costs and Benefit Cuts in 2027

Medicare Advantage beneficiaries across the United States are confronting significant changes to their coverage as the open enrollment period runs through December 7, 2027. While federal regulators describe the upcoming plan options as stable, major private insurers are raising out-of-pocket costs, narrowing provider networks, and cutting supplemental benefits to address a sharp spike in medical utilization and healthcare costs over recent years.

Major industry players are also terminating coverage for a substantial number of enrollees. The nation's two largest Medicare Advantage providers, UnitedHealthcare and Humana, are collectively discontinuing plans that affect nearly one million people. UnitedHealth Group confirmed that roughly 390,000 members will be impacted by plan closures, while Humana is phasing out policies affecting approximately 600,000 individuals, representing about 8% of its total Medicare Advantage membership.

Insurers are shifting away from preferred provider organization plans in favor of health maintenance organizations and special needs plans. According to industry experts, HMOs and special needs plans grant companies tighter control over medical utilization through narrower networks and higher cost-sharing requirements. Particularly, chronic condition special needs plans have emerged as a major growth driver for the market as carriers seek higher margins from sicker enrollees.

In addition to plan cancellations, enrollees who keep their coverage will likely see diminished benefits. An analysis of the Medicare Plan Finder revealed that major carriers, including Clover Health, UnitedHealthcare, Humana, and Centene, have reduced dental benefits and increased cost-sharing. Furthermore, the era of zero-dollar premiums is receding, with approximately four million standalone Part D drug plan enrollees losing their zero-dollar premium options, alongside a reduction in zero-dollar Medicare Advantage plans.

Open enrollment also brings notable shifts in prescription drug coverage under Medicare Part D. The annual out-of-pocket spending threshold is rising from $2,100 to $2,400, and the standard deductible is increasing from $615 to $700. Additionally, the Centers for Medicare & Medicaid Services is ending its temporary Part D Premium Stabilization Demonstration, which may cause monthly premiums to tick upward for some beneficiaries as the program returns to traditional market conditions.

At the same time, the federal government is implementing negotiated prices for 15 additional high-cost drugs under the Drug Price Negotiation Program, which includes widely used medications such as Ozempic, Wegovy, and Rybelsus. Federal health officials project that these negotiated prices will reduce out-of-pocket prescription expenses for beneficiaries by approximately $685 million during the year.

Financial analysts note that while seniors will receive a 3.6 percent Social Security cost-of-living adjustment, adding an estimated $75 to the average retired worker's monthly benefit, rising healthcare expenses could fully absorb that increase. Experts advise beneficiaries to carefully review their plan options, drug deductibles, and network changes before the enrollment deadline to avoid unexpected medical bills when new coverage takes effect on January 1.